Search Within

Sean McCarthy Devlin

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (49)
  2. Journal Article (43)
  3. Research Letter (2)
Groups
  1. Biostatistics Service (94)
  2. Center for Hematologic Malignancies (94)
  3. Department of Medicine (94)
  4. Epidemiology and Biostatistics (94)
  5. GSK Faculty (94)
  6. Hematologic Malignancies, Division of (94)

More Groups

People
  1. Sergio Giralt (55)
  2. Miguel-Angel Perales (45)
  3. Marcel Van Den Brink (43)
  4. Ross Levine (39)
  5. Jonathan Peled (38)
  6. Doris Ponce (29)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (9)
  4. 2021 (14)
  5. 2020 (11)
  6. 2019 (11)

More Years

Publications
  1. Blood (36)
  2. Biology of Blood and Marrow Transplantation (17)
  3. Blood Advances (5)
  4. Journal of Clinical Oncology (3)
  5. Transplantation and Cellular Therapy (3)
  6. American Journal of Hematology (2)

More Publications

Publishers
  1. American Society of Hematology (41)
  2. Elsevier Inc. (20)
  3. American Association for Cancer Research (6)
  4. Nature Publishing Group (6)
  5. American Association for the Advancement of Science (3)
  6. American Society of Clinical Oncology (3)

More Publishers

Results (94)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Response to hypomethylating agent therapy in acute myeloid leukemia based upon mutations in the DNA methylation pathway
    Meeting Abstract

    Coombs, C. C.; Devlin, S.; Dixit, S.; Mohanty, A.; Knapp, K. M.; Arcila, M.; Klimek, V. M.; Tallman, M. S.; Levine, R. L.; Rampal, R. K.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia
    Journal Article

    Tiacci, E.; Park, J. H.; De Carolis, L.; Chung, S. S.; Broccoli, A.; Scott, S.; Zaja, F.; Devlin, S.; Pulsoni, A.; Chung, Y. R.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • High disease-free survival with enhanced protection against relapse after double-unit cord blood transplantation when compared with T cell-depleted unrelated donor transplantation in patients with acute leukemia and chronic myelogenous leukemia
    Journal Article

    Ponce, D. M.; Hilden, P.; Devlin, S. M.; Maloy, M.; Lubin, M.; Castro-Malaspina, H.; Dahi, P.; Hsu, K.; Jakubowski, A. A.; Kernan, N. A.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Intestinal Blautia is associated with reduced death from graft-versus-host disease
    Journal Article

    Jenq, R. R.; Taur, Y.; Devlin, S. M.; Ponce, D. M.; Goldberg, J. D.; Ahr, K. F.; Littmann, E. R.; Ling, L.; Gobourne, A. C.; Miller, L. C.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Intensified mycophenolate mofetil dosing and higher mycophenolic acid trough levels reduce severe acute graft-versus-host disease after double-unit cord blood transplantation
    Journal Article

    Harnicar, S.; Ponce, D. M.; Hilden, P.; Zheng, J.; Devlin, S. M.; Lubin, M.; Pozotrigo, M.; Mathew, S.; Adel, N.; Kernan, N. A.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • In landmark analysis the severity of day 100 acute graft-versus-host disease (aGVHD) has no impact on long-term progression-free survival (PFS) after double-unit cord blood transplantation (DCBT)
    Meeting Abstract

    Ponce, D. M.; Devlin, S.; Bhatt, V.; Pozotrigo, M.; Lubin, M.; Lauer, E.; Kernan, N. A.; Scaradavou, A.; Hanash, A. M.; Perales, M. A.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation
    Journal Article

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S. M.; Lubin, M.; Giralt, S.; Goldberg, J. D.; Hanash, A.; Hsu, K.; Jenq, R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Telomere length is associated with specific mutations and mutation classes in patients with acute myeloid leukemia
    Meeting Abstract

    Watts, J. M.; Dumitriu, B.; Hilden, P.; Chen, C.; Rapaport, F.; Kishtagari, A.; Ahn, J.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • High day 28 ST2 biomarker levels predict severe day 100 acute graft-versus-host disease and day 180 transplant-related mortality after double-unit cord blood transplantation
    Meeting Abstract

    Ponce, D. M.; Hilden, P.; Mumaw, C.; Devlin, S.; Lubin, M.; Evans, K.; Prockop, S. E.; Scaradavou, A.; Kernan, N.; Giralt, S. A.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • High-throughput mutational profiling of post-myeloproliferative neoplasm acute myeloid leukemia reveals frequent mutations in NRAS in JAK2V617F-negative post-MPN AML
    Meeting Abstract

    Rampal, R. K.; Devlin, S. M.; McKenney, A. S.; Knapp, K. M.; Patel, M.; Wang, K.; Nahas, M. K.; Yelensky, R.; Otto, G. A.; Lipson, D.; more...
    Blood (2013)

    Fulltext@MSK | Save